3F8
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for 3F8, covering 2013-10-16 to 2019-11-14. Get the full timeline:
Most recent: Clinical Trial Update: 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of Second or Greater Remission of High-Risk Neuroblastoma [Phase 2]